Showing results (101-110 of 419) with videos related to
Sort By:
Pageof 42
Cancer Research|October 3, 2008
Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculaturePaulo Cesar Maciag, Matthew M Seavey, Zhen-Kun Pan, et al.Cancer Letters|February 16, 2024
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinomaGiulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.Acta Neuropathologica|June 2, 2007
WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?Matthias Mehling, Perikles Simon, Michel Mittelbronn, et al.Annals of the New York Academy of Sciences|January 15, 2005
Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanismsChien-Chung Chang, Michael Campoli, Wei Luo, et al.Cancer Immunology, Immunotherapy : CII|July 12, 2007
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaAkash M Mehta, Ekaterina S Jordanova, Gemma G Kenter, et al.European Journal of Immunology|February 21, 2003
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligationPaola Contini, Massimo Ghio, Alessandro Poggi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Genetic evolution of T-cell resistance in the course of melanoma progressionAntje Sucker, Fang Zhao, Birgit Real, et al.Journal of Translational Medicine|January 7, 2021
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutationEster Simeone, Giosuè Scognamiglio, Mariaelena Capone, et al.Oncotarget|February 11, 2016
Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cellsSofia R Gameiro, Anthony S Malamas, Kwong Y Tsang, et al.Cancer Research|September 20, 2006
HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic markerTakeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii, et al.Pageof 42